ArticleToxicology reports2026
Circulating miR-126 and miR-155 are associated with environmental lead exposure: A translational approach via human biomonitoring and bioinformatic networks.
Article in Toxicology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exposure to environmental contaminants, particularly lead (Pb), has increased due to anthropogenic activities and has been associated with epigenetic alterations, including changes in microRNA (miRNA) expression. Certain miRNAs have emerged as potential biomarkers of environmental exposure and early biological effects. Among them, miR-126 and miR-155 have been reported to be responsive to lead exposure. In this exploratory study, we evaluated circulating levels of miR-126 and miR-155 in a Mexican population environmentally exposed to lead and performed bioinformatic analyses to investigate the biological pathways potentially regulated by these miRNAs. Our results showed a mean blood lead concentration of 7.6 ± 5.8 μg/dL, with more than 50 % of participants exceeding the Mexican reference value (≥5 μg/dL; NOM-199-SSA1-2000). Both miRNAs showed significantly altered expression patterns associated with elevated blood lead levels (p < 0.05). Gene Ontology and KEGG pathway analyses of predicted target genes revealed enrichment in pathways related to inflammation, angiogenesis, lipid metabolism, and atherosclerosis, including AGE-RAGE signaling, TNF, Toll-like receptor, and fluid shear stress-related pathways. Protein-protein interaction network analysis identified MYC as a shared regulatory node, suggesting coordinated regulation of biological processes relevant to cardiovascular function. Together, these findings indicate that lead exposure is associated with altered circulating miR-126 and miR-155 expression and with modulation of pathways related to cardiovascular health. Although causal inferences cannot be drawn due to the observational design, these results provide a framework for future large-scale epidemiological and functional studies aimed at elucidating epigenetic responses to environmental lead exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.